Shilpa Medicare Ltd share price logo

Shilpa Medicare Share Price (SHILPAMED)

Check the latest share price of Shilpa Medicare, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹905.91.02%

as on 04:01PM, 14 Jul 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Shilpa Medicare Stock Performance

Get live Shilpa Medicare share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹875
    Day's Price Range
    ₹910.75
  • 52 Week's Low

    52 Week's High

    ₹555
    52-Week Price Range
    ₹1,000
1 Month Return-8.83 %
3 Month Return+ 36.77 %
1 Year Return+ 37.09 %
3 Year Return+ 115.1 %
5 Year Return+ 82.47 %
Previous Close₹896.75
Open₹896.50
Volume48.92K
Upper Circuit₹941.55
Lower Circuit₹851.95

Shilpa Medicare Fundamentals & Key Indicators

Check Shilpa Medicare market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹8,769.40 Cr

Return on Equity (ROE)

1.59

PE Ratio (TTM)

111.81

Return on capital employed (ROCE)

2.77

Industry PE ratio

51.69

Beta (LTM)

1.26

P/B Ratio

1.87

Dividend Yield

0

PEG Ratio

25.76

Quarterly Earnings Growth YOY

-40.78

EPS (TTM)

3.68

Sector

Pharmaceuticals

Book Value

208.37

Technical Analysis

How to invest in Shilpa Medicare?

Investing in Shilpa Medicare is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Shilpa Medicare or SHILPAMED on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Shilpa Medicare or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Shilpa Medicare with just a few clicks!

Shilpa Medicare Stock's Interest Amongst Investors

-63%

Period Jul 14, 2025 to Jun 14, 2025. Change in 30 Days vs previous period

Search interest for Shilpa Medicare Ltd Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Shilpa Medicare Valuation

Track how Shilpa Medicare P/E has moved over time to understand its valuation trends.

Shilpa Medicare in the last 5 years

  • Overview

  • Trends

Lowest (-6579.29x)

March 28, 2024

Industry (51.69x)

July 11, 2025

Today (111.81x)

July 11, 2025

Highest (503.73x)

February 21, 2023

LowHigh

Today’s Price to Earnings Ratio: 111.81x

Shilpa Medicare Stock Recommendation

Get updated buy, sell, and hold recommendations by analysts on Shilpa Medicare.

based on 2 analysts

BUY

50.00%

Buy

50.00%

Hold

0.00%

Sell

50% of analysts recommend a 'BUY' rating for Shilpa Medicare. Average target price of ₹973.5

Source: S&P Global Market Intelligence

Shilpa Medicare Share Price Target

Get share price movements and forecasts by analysts on Shilpa Medicare.

Shilpa Medicare price forecast by 2 analysts

Upside of8.56%

High

₹1090

Target

₹973.50

Low

₹857

Shilpa Medicare target price ₹973.5, a slight upside of 8.56% compared to current price of ₹905.9. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Shilpa Medicare Financial Results

Get the annual and quarterly financial summary of Shilpa Medicare, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

292 (0%)293 (0%)344 (18%)319 (7%)331 (4%)
Net Income

(in ₹ Cr)

24 (0%)14 (43%)18 (28%)32 (77%)15 (54%)
Net Profit Margin8.40% (0%)4.81% (43%)5.22% (9%)9.95% (91%)4.39% (56%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

2555 (0%)2966 (16%)2597 (12%)2501 (4%)
Total Liabilities

(in ₹ Cr)

917 (0%)900 (2%)480 (47%)359 (25%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

130 (0%)70 (46%)174 (150%)2 (99%)8 (286%)

Indices Featuring Shilpa Medicare Stock

Check stock indices that include Shilpa Medicare.

BSE Healthcare

₹44,841.24

1.15 (511.27%)

BSE Small-Cap

₹54,796.82

0.57 (312.06%)

Shilpa Medicare Earnings and Dividends

View detailed summary of the earnings and dividend history of Shilpa Medicare.

  • Shilpa Medicare Ltd Earnings Results

    Shilpa Medicare Ltd’s net profit fell -40.78% since last year same period to ₹14.51Cr in the Q4 2024-2025. On a quarterly growth basis, Shilpa Medicare Ltd has generated -54.34% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Shilpa Medicare Ltd Dividends May,2022

    In the quarter ending March 2022, Shilpa Medicare Ltd has declared dividend of ₹1.10 - translating a dividend yield of 0.25%.

    Read More about Dividends

Shilpa Medicare Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Shilpa Medicare.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
44.23%
0.00
Foreign Institutions
10.97%
0.00
Mutual Funds
4.05%
0.00
Retail Investors
37.25%
0.00
Others
3.5%
0.00

Shilpa Medicare vs Peers

Compare market cap, revenue, PE, and other key metrics of Shilpa Medicare with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY8,769.4016.49%0.53311,151
BUY38,943.4256.09%0.523001,051
BUY18,569.6019%0.57726,702
NA5,170.93-0.59%0.79-38875
BUY15,508.9747.85%0.672441,515

Shilpa Medicare News & Key Events

Latest news and events in one place to help you make informed investing decisions in Shilpa Medicare.

  • Shilpa Medicare Secures SFDA GMP Certification - 10 Jul, 2025

    Shilpa Medicare's Unit VI facility in Bengaluru received GMP certification from the Saudi Food and Drug Authority, following a thorough inspection with zero observations. This facility manufactures oral films and transdermal patches, supplying to markets including the US and Australia.
  • Shilpa Medicare Subsidiary Passes GMP Inspection - 04 Jul, 2025

    Shilpa Medicare's subsidiary, Shilpa Pharma Lifesciences, successfully completed a GMP inspection by ANVISA with no major observations, reinforcing its compliance and international expansion efforts.
  • Shilpa Medicare Positioned for Market Share Growth - 29 Jun, 2025

    Shilpa Medicare, along with Alembic Pharmaceuticals and other firms, is well-positioned to gain market share in the US, particularly in differentiated products like injectables and respiratory therapies.

Insights on Shilpa Medicare Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 320.79 Cr → 340.68 Cr (in ₹), with an average increase of 5.8% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 9.90% to 10.97% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 49.4% return, outperforming this stock by 12.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.23% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 121.0% return, outperforming this stock by 5.9%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 37.60% to 37.25% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SHILPAMED stock has moved down by -8.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 31.78 Cr → 14.51 Cr (in ₹), with an average decrease of 54.3% per quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 4.89% to 4.05% in Mar 2025 quarter

About Shilpa Medicare

Shilpa Medicare Limited (SML) was established in 1987 and converted to a public limited company in 1993. They are one of the leading API and formulations manufacturers, with expertise in oncology and non-oncology medicines, with over 44 APIs and 16 injectable dosage forms and 19 oral solid dosage forms. SML deploy sophisticated technology in order to comply with international standards. In 2015, funds were raised by allotting 1.76 Mn equity shares at Rs. 423/ share, and in 2016, the face value of equity shares was split into two equity shares of Rs.1/ each. Raichem Medicare Pvt. Ltd., a subsidiary of SML successfully installed all machinery and recruited personnel. During FY16, they launched generic versions of Vidaza Injection and Xeloda Tablets. In 2017, Navya Biologicals Private Limited was acquired and in 2019, they invested Rs 22.71 cr in Shilpa Therapeutics Pvt. Ltd and disinvested 24% stake in Raichem Medicare Pvt. Ltd. In 2021, they launched a pediatric dose paracetamol oral thin film, Molshil and acquired stake in FTF Pharma Pvt. Ltd, Koanaa Healthcare Canada, etc. In 2022, they approved Slump sale of Active Pharmaceutical Ingredient API Business to Shilpa Pharma Lifesciences Limited.

Revenue: ₹330.80Cr as on March 2025 (Q4 FY25)
Net Profit: ₹14.51Cr as on March 2025 (Q4 FY25)
Listing date: 03 Dec, 2009
Chairperson Name: Omprakash Inani
OrganisationShilpa Medicare Ltd
IndustryPharmaceuticals
CEOOmprakash Inani
E-voting on sharesClick here to vote

FAQs

What is Shilpa Medicare share price today?

Shilpa Medicare share price today stands at ₹905.9, Open: ₹896.5, Previous Close: ₹896.75, High: ₹910.75, Low: ₹875, 52 Week High: ₹1000, 52 Week Low: ₹555.

What is today's traded volume of Shilpa Medicare?

Today's traded volume of Shilpa Medicare is 48.92K. Which means that 48.92K shares of Shilpa Medicare were bought and sold on the stock market during today's trading session.

What is Shilpa Medicare's market cap today?

Today's market capitalisation of Shilpa Medicare is ₹8,769.40 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Shilpa Medicare?

Shilpa Medicare’s 52 week high is ₹1000 and 52 week low is ₹555. The current share price of Shilpa Medicare is ₹905.9, which is -9.41% down from its 52 week high and 63.23% up from its 52 week low.